MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, OVID has $225,628K in assets. $27,359K in debts. $94,064K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1016.92%
Quick Ratio
1016.92%
Cash Ratio
597.31%
Debt to Asset Ratio
12.13%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Long-term equity investments
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Lease liability
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
94,064 13,153 20,611 28,415
Marketable securities
61,458 56,482 4,992 9,932
Prepaid expenses and other current assets
4,623 4,733 3,221 3,742
Total current assets
160,145 74,368 28,824 42,089
Marketable securities - noncurrent
10,076 20,812 --
Long-term equity investments
41,961 41,961 20,908 20,908
Restricted cash
1,931 1,931 1,931 1,931
Other assets
-0 0 0
Right-of-use asset, net
11,298 11,610 11,916 12,215
Property and equipment, net
217 252 269 285
Total assets
225,628 150,934 63,848 77,428
Deferred revenue
--718 718
Accounts payable
8,876 1,956 1,710 3,950
Accrued expenses
5,413 4,899 2,959 2,872
Current portion, lease liability
1,459 1,433 1,409 1,384
Total current liabilities
15,748 8,288 6,796 8,924
Lease liability
11,611 11,986 12,354 12,715
Total liabilities
27,359 20,274 19,150 21,639
Common stock, 0.001 par value 315,000,000 shares authorized 167,266,466 and 130,184,353 shares issued and outstanding at march31, 2026 and december31, 2025, respectively
167 130 71 71
Additional paid-in-capital
537,225 452,445 376,129 375,005
Accumulated other comprehensive loss
-422 -202 -126 -69
Accumulated deficit
-338,701 -321,713 -331,376 -319,218
Total stockholders equity
198,269 130,660 44,698 55,789
Total liabilities and stockholders equity
225,628 150,934 63,848 77,428
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$94,064K Marketable securities$61,458K Prepaid expenses andother current assets$4,623K Total current assets$160,145K Long-term equityinvestments$41,961K Right-of-use asset, net$11,298K Marketable securities -noncurrent$10,076K Restricted cash$1,931K Property and equipment,net$217K Total assets$225,628K Total liabilities andstockholders equity$225,628K Total stockholdersequity$198,269K Total liabilities$27,359K Accumulated deficit-$338,701K Accumulated othercomprehensive loss-$422K Additionalpaid-in-capital$537,225K Total currentliabilities$15,748K Lease liability$11,611K Common stock, 0.001 parvalue 315,000,000...$167K Accounts payable$8,876K Accrued expenses$5,413K Current portion, leaseliability$1,459K

Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Inc. (OVID)